MEDIROM Healthcare Technologies Inc. Receives Nasdaq Delisting Notice and Requests Hearing

11/19/2026
Impact: -65
Consumer Cyclical

MEDIROM Healthcare Technologies said Nasdaq notified it on November 13, 2026, that it had failed to file its 2025 Form 20-F within an extended deadline. Nasdaq indicated the company’s American Depositary Shares would face trading suspension and delisting beginning November 24. MEDIROM requested a hearing to appeal, automatically staying suspension for 15 days, and sought an extension through the hearing; it also remains out of compliance with Nasdaq’s minimum bid-price requirement.

AI summary, not financial advice

Share: